The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Oxo-6-(4-phenoxyphenyl)hexylphosphonic Acid Dipotassium Salt ID: ALA449115
PubChem CID: 44185387
Max Phase: Preclinical
Molecular Formula: C18H19K2O5P
Molecular Weight: 348.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCCc1cccc(Oc2ccccc2)c1)CP(=O)([O-])[O-].[K+].[K+]
Standard InChI: InChI=1S/C18H21O5P.2K/c19-16(14-24(20,21)22)9-5-4-7-15-8-6-12-18(13-15)23-17-10-2-1-3-11-17;;/h1-3,6,8,10-13H,4-5,7,9,14H2,(H2,20,21,22);;/q;2*+1/p-2
Standard InChI Key: YWVMNNNQCNTPIX-UHFFFAOYSA-L
Molfile:
RDKit 2D
26 25 0 0 0 0 0 0 0 0999 V2000
6.2747 -18.2374 0.0000 K 0 0 0 0 0 15 0 0 0 0 0 0
-5.3779 -19.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3792 -20.0274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6662 -20.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9469 -20.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9500 -19.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6681 -18.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2376 -18.7798 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5210 -19.1888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5196 -20.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8039 -20.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0904 -20.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0973 -19.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8135 -18.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3863 -18.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3317 -19.1638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0426 -18.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7606 -19.1517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4715 -18.7332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1895 -19.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4645 -17.9081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9004 -18.7211 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.6063 -18.3015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3204 -19.4311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4837 -18.0090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7622 -20.7765 0.0000 K 0 0 0 0 0 15 0 0 0 0 0 0
12 13 1 0
2 3 2 0
13 14 2 0
14 9 1 0
6 7 2 0
13 15 1 0
7 2 1 0
15 16 1 0
16 17 1 0
6 8 1 0
17 18 1 0
3 4 1 0
18 19 1 0
8 9 1 0
19 20 1 0
19 21 2 0
9 10 2 0
20 22 1 0
4 5 2 0
22 23 1 0
10 11 1 0
22 24 1 0
22 25 2 0
11 12 2 0
5 6 1 0
M CHG 4 1 1 23 -1 24 -1 26 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.33Molecular Weight (Monoisotopic): 348.1127AlogP: 3.94#Rotatable Bonds: 9Polar Surface Area: 83.83Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.68CX Basic pKa: ┄CX LogP: 3.34CX LogD: 0.97Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.53Np Likeness Score: 0.12
References 1. Song Y, Liu CI, Lin FY, No JH, Hensler M, Liu YL, Jeng WY, Low J, Liu GY, Nizet V, Wang AH, Oldfield E.. (2009) Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results., 52 (13): [PMID:19456099 ] [10.1021/jm9001764 ]